COVID-19 2024–2025 vaccines are recommended for everyone aged 6 months and older, with vaccines targeting the JN.1 and KP.2 strains of SARS-CoV-2.

The Centers for Disease Control and Prevention (CDC) has updated its recommendations regarding COVID-19 vaccinations for ...

Stay informed with the latest news on COVID-19 and vaccines from the editors at U.S. News. (Braulio Jatar|SOPA Images (Braulio Jatar|SOPA Images Despite a summer surge, the disease that's killed ...

The new COVID-19 vaccine rolled out across the country last month, giving people access to the most recent versions of the Moderna, Pfizer, and Novavax shots. But, given that you have options ...

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Researchers evaluated protection conferred by a single COVID-19 mRNA vaccine dose vs a 2-dose series in the setting of high preexisting SARS-CoV-2 immunity.

Updated COVID-19 vaccination for this year have been available since March. Only about 11.7% of American adults have been ...

Although COVID-19 has been somewhat controlled, it is still present in forms of different strains, which is why Pfizer, Moderna and Novavax have introduced a new vaccine shot to the public to keep up ...

Fleet Street legend and Mirror columnist, Paul Routledge, sends gentle tales from his West Yorkshire allotment, Mrs R’s ...

Your test may show an expired date on the box. The minute it arrives ... that October is a prime time to get vaccinated.Vaccines for COVID-19, flu and RSV are available now.

Barely three years ago, Pfizer was the toast of the pharmaceutical world and Bourla, who was elevated to the top job in 2019, wrote a book about the race to develop the coronavirus vaccine.